Mountain View, CA, United States of America

Neuropace, Inc.


USPTO Granted Patents = 204

% Expired Patents = 27.9



Trademarks = 4

Forward Citations = 11,384

Loading Chart...
Loading Chart...

54 inventors (with patents filed for the assignee):

goldMedal Benjamin D Pless (75 out of 118 patents)

silverMedal Thomas K Tcheng (46 out of 49 patents)

bronzeMedal Brett M Wingeier (38 out of 78 patents)

4 David R Fischell (29 out of 217 patents)

5 Robert E Fischell (20 out of 208 patents)

6 Stephen T Archer (19 out of 30 patents)

7 Felice Sun (19 out of 19 patents)

8 Barbara Gibb (19 out of 21 patents)

9 David A Greene (18 out of 20 patents)

10 Martha J Morrell (17 out of 17 patents)

11 Adrian R M Upton (17 out of 18 patents)

12 C Lance Boling (14 out of 22 patents)

13 Sharanya Arcot Desai (13 out of 13 patents)

14 Dennis Potts (12 out of 12 patents)

15 Joseph Vandenburg (12 out of 14 patents)


Core Competencies:
Neurostimulation
Seizure Detection
Therapeutic Optimization
Implantable Devices
Physiological Records
Machine Learning
Brain Sensing
Lead Fixation
Data Compression
Clinical Decision Making
Neural Interfaces
Current Management

204 patents:

NeuroPace, Inc. is a medical technology company pioneering in the field of responsive neurostimulation. They develop and market implantable devices for the treatment of neurological disorders, specializing in epilepsy. Their innovative RNS® System is designed to detect abnormal brain activity and deliver electrical stimulation to reduce the occurrence of seizures in patients. NeuroPace is committed to improving the quality of life for individuals with epilepsy through advanced neurotechnology.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Neuropace, Inc.
204 Patents

#18 in Mountain View, CA

#443 in California

#2,030 in US

#4,151 in the World

Mountain View, CA (US)
Mountain View, CA, United States of America
Forward Citations = 11,384

54 inventors:

Please report any incorrect information to [email protected]
Loading…